(Q43913157)

28 November 2017

Individualising HIV treatment--pharmacogenetics and immunogenetics (English)

1 reference

28 November 2017

1

Amalio Telenti

1 reference

28 November 2017

Vincent Aubert

2

1 reference

PubMed ID

11888578

28 November 2017

François Spertini

series ordinal

3

1 reference

PubMed ID

11888578

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

359

1 reference

28 November 2017

9308

1 reference

28 November 2017

722-723

1 reference

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Predictive drug allergy testing: an alternative viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Fixed drug eruptions with feprazone are linked to HLA-B22

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Considering genetic profiles in functional studies of immune responsiveness to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Population genetic structure of variable drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

Frequency of C3435T polymorphism of MDR1 gene in African people

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907899-6

7 January 2021

10.1016/S0140-6736(02)07899-6

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11888578